| 1 |
31240708 | Adipocytes utilize sucrose as an energy source-Effect of different carbohydrates on adipocyte differentiation. | 2020 Feb |
1 |
| 2 |
31392349 | Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways. | 2020 May |
2 |
| 3 |
32190036 | Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers. | 2020 |
1 |
| 4 |
33481370 | [Role of leptin and nuclear receptor PPARγ in PCOS pathogenesis]. | 2020 Dec 6 |
2 |
| 5 |
30458368 | Organotins in obesity and associated metabolic disturbances. | 2019 Feb |
1 |
| 6 |
28651828 | Influence of expression of UCP3, PLIN1 and PPARG2 on the oxidation of substrates after hypocaloric dietary intervention. | 2018 Aug |
1 |
| 7 |
30702076 | THE ROLE OF PRO12ALA POLYMORPHISM OF THE PPAR-Γ GENE IN THE GENESIS OF THE GESTATIONAL WEIGHT GAIN. | 2018 Dec |
2 |
| 8 |
27916646 | Roles of Peroxisome Proliferator-Activated Receptor β/δ in skeletal muscle physiology. | 2017 May |
1 |
| 9 |
28947679 | Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut. | 2017 Nov |
2 |
| 10 |
29203734 | Effect of pioglitazone on insulin resistance, progression of atherosclerosis and clinical course of coronary heart disease. | 2017 |
1 |
| 11 |
26018229 | Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity. | 2016 |
1 |
| 12 |
27197753 | F-box only protein 9 is an E3 ubiquitin ligase of PPARγ. | 2016 May 20 |
2 |
| 13 |
26322090 | Gestational diabetes mellitus is associated with increased leukocyte peroxisome proliferator-activated receptor γ expression. | 2015 Aug 12 |
2 |
| 14 |
24374061 | PPARγ activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. | 2014 Mar |
2 |
| 15 |
24464185 | Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population. | 2014 May |
2 |
| 16 |
24779289 | Effects of the C161T polymorphism in the gene of peroxisome proliferators activated receptor γ on changes of plasma lipid and apolipoprotein ratios induced by a high carbohydrate diet in a healthy Chinese Han young population. | 2014 |
1 |
| 17 |
22528626 | Lifestyle factors modify obesity risk linked to PPARG2 and FTO variants in an elderly population: a cross-sectional analysis in the SUN Project. | 2013 Jan |
1 |
| 18 |
23176218 | Potential effect of angiotensin II receptor blockade in adipose tissue and bone. | 2013 |
2 |
| 19 |
23569420 | Diverse coactivator recruitment through differential PPARγ nuclear receptor agonism. | 2013 Mar |
1 |
| 20 |
23891824 | Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients. | 2013 Oct 25 |
1 |
| 21 |
24379269 | [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance]. | 2013 Dec 11 |
1 |
| 22 |
24497707 | Distribution and genotype frequency of the C1431T and pro12ala polymorphisms of the peroxisome proliferator activator receptor gamma gene in an Iranian population. | 2013 Oct |
2 |
| 23 |
22122458 | Effects of PPARγ ligands on vascular tone. | 2012 Jun |
2 |
| 24 |
22731403 | Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. | 2012 |
1 |
| 25 |
23077903 | [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II]. | 2012 Jan-Mar |
2 |
| 26 |
21533120 | Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes. | 2011 Apr 18 |
1 |
| 27 |
21666962 | Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus. | 2011 Mar-Apr |
1 |
| 28 |
21687509 | Pleiotropic effects of glitazones: a double edge sword? | 2011 |
2 |
| 29 |
21911496 | Endothelial surface N-glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligands. | 2011 Nov 4 |
1 |
| 30 |
20158092 | [Recent trends in PPARgamma agonist development of thiazolidinediones and non-thiazolidinediones]. | 2010 Feb |
2 |
| 31 |
20158101 | [Protective role of PPARgamma agonists against cardiovascular disease]. | 2010 Feb |
1 |
| 32 |
18818299 | The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism. | 2009 Jan |
1 |
| 33 |
19172745 | Structural basis for the activation of PPARgamma by oxidized fatty acids. | 2008 Sep |
1 |
| 34 |
20409934 | Does it matter how blood pressure is lowered in patients with metabolic risk factors? | 2008 Jul-Aug |
1 |
| 35 |
18159845 | [The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma and immunological processes in patients with type 2 diabetes and insulin resistance]. | 2007 |
2 |
| 36 |
16154710 | Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation. | 2006 |
1 |
| 37 |
16511590 | PPAR gamma and human metabolic disease. | 2006 Mar |
2 |
| 38 |
16968414 | Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? | 2006 Oct |
1 |
| 39 |
15617852 | Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. | 2005 |
1 |
| 40 |
15673477 | PPAR gamma as a metabolic regulator: insights from genomics and pharmacology. | 2005 Jan 25 |
1 |
| 41 |
15868121 | Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator. | 2005 Apr |
1 |
| 42 |
15940190 | [Clinical genetic determinants of carbohydrate metabolism disturbances in patients with hypertension and excessive weight]. | 2005 |
1 |
| 43 |
12829631 | Expression of peroxisome proliferator-activated receptor-gamma1 and peroxisome proliferator-activated receptor-gamma2 in visceral and subcutaneous adipose tissue of obese women. | 2003 Jul |
1 |
| 44 |
11395869 | [Current and future aspects of oral antidiabetic agents in type 2 diabetes]. | 2001 May |
1 |
| 45 |
11965833 | Current treatment of insulin resistance in type 2 diabetes mellitus. | 2000 Oct |
1 |
| 46 |
10591673 | Peroxisome proliferator-activated receptor gamma gene locus is related to body mass index and lipid values in healthy nonobese subjects. | 1999 Dec |
2 |